Myriad Genetics Inc (NASDAQ:MYGN)

27.40
BATS BZX Real-Time Price
As of 3:21pm ET
 -1.37 / -4.75%
Today’s Change
10.54
Today|||52-Week Range
33.97
+38.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues200.9M202.3M216.8M216.6M
 
 
 
 
 
Cost of Goods Sold30.6M31.4M40.2M36.3M
 
 
 
 
 
Depreciation And Amortization15.1M18.3M18.0M18.3M
 
 
 
 
 
 
Operating ExpensesGross Income155.2M152.6M158.6M162.0M
 
 
 
 
 
General Expenses139.1M151.0M147.6M151.9M
 
 
 
 
 
Research And Development17.7M21.1M21.8M21.4M
 
 
 
 
 
Total Operating Expenses184.8M200.7M205.8M206.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income16.1M1.6M11.0M10.1M
 
 
 
 
 
Extraordinary Charge-200.0K-400.0K-4.9M-4.2M
 
 
 
 
 
Interest Expense On Debt1.1M2.2M3.4M3.2M
 
 
 
 
 
Other Expenses800.0K1.1M0.00-100.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income16.1M800.0K3.6M3.3M
 
 
 
 
 
Income Taxes-3.0M-1.6M-1.0M-3.6M
 
 
 
 
 
Minority Interest0.00-100.0K0.000.00
 
 
Net Income13.1M-700.0K2.6M6.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS70.1M73.0M74.2M73.3M
 
 
 
 
 
Shares To Calculate EPS Diluted72.9M73.0M76.5M74.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.18-$0.01$0.03$0.09
 
 
 
 
 
EPS Diluted$0.18-$0.01$0.03$0.09